Regular check-ins with your doctor allow for ongoing assessment of blood sugar levels, kidney function, and any side effects that may develop over time
Insurance Coverage Framework and Cost Responsibility Coverage decisions for GLP-1 medications depend on your plan tier, deductible status, and whether you meet your insurer's clinical criteria
Slower digestion can reduce bowel movement frequency, especially if fluid or fiber intake is low
Phase 2 trial data Tirzepatide Phase 3 trials (SURPASS and SURMOUNT programs) demonstrated weight loss of 15 to 22.5% body weight depending on dose and study population
This selectivity is why hunger is less of an issue compared to older GHRPs, but the effect is not completely absent for everyone
The most common side effects are gastrointestinal nausea, vomiting, diarrhea, and constipation